Microneedles for controlled and sustained intraocular drug delivery
Abstract Microneedles (MNs) have emerged as a promising technology for minimally invasive drug delivery, offering significant advantages in the treatment of ocular diseases. These miniaturized needles enable precise, localized drug delivery directly into specific tissues of the eye, such as the corn...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | NPG Asia Materials |
| Online Access: | https://doi.org/10.1038/s41427-025-00614-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226157363298304 |
|---|---|
| author | Junsang Lee Jinheon Jeong Van Phuc Nguyen Seokkyoon Hong Yannis M. Paulus Chi Hwan Lee |
| author_facet | Junsang Lee Jinheon Jeong Van Phuc Nguyen Seokkyoon Hong Yannis M. Paulus Chi Hwan Lee |
| author_sort | Junsang Lee |
| collection | DOAJ |
| description | Abstract Microneedles (MNs) have emerged as a promising technology for minimally invasive drug delivery, offering significant advantages in the treatment of ocular diseases. These miniaturized needles enable precise, localized drug delivery directly into specific tissues of the eye, such as the cornea, sclera, vitreous, or retina, while minimizing pain and discomfort. MNs can be fabricated from various biocompatible materials, including metals, silicon, and biodegradable polymers, making them highly adaptable to various clinical applications. Recent advancements in MN design include the integration of 3D printing technologies to create highly customized geometries for improved drug delivery precision, the use of smart materials that enable stimuli-responsive and sustained drug release, and the development of hybrid microneedles combining different polymers to enhance both mechanical strength and controlled drug release. These innovations have established MNs as a superior alternative to traditional methods like eye drops or intravitreal injections, which often face issues of limited bioavailability and patient compliance. This review summarizes the current state of research on MN-based ocular drug delivery, focusing on material developments, fabrication methods, drug release mechanisms, and implantation techniques. Future directions for MN technology in ophthalmology are also discussed, highlighting its potential to improve treatment outcomes for complex ocular diseases. |
| format | Article |
| id | doaj-art-b005dc74759a4d19a3729cf7f8bc6e46 |
| institution | Kabale University |
| issn | 1884-4057 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | NPG Asia Materials |
| spelling | doaj-art-b005dc74759a4d19a3729cf7f8bc6e462025-08-24T11:35:59ZengNature PortfolioNPG Asia Materials1884-40572025-08-0117112610.1038/s41427-025-00614-7Microneedles for controlled and sustained intraocular drug deliveryJunsang Lee0Jinheon Jeong1Van Phuc Nguyen2Seokkyoon Hong3Yannis M. Paulus4Chi Hwan Lee5Weldon School of Biomedical Engineering, Purdue UniversityWeldon School of Biomedical Engineering, Purdue UniversityDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins UniversityWeldon School of Biomedical Engineering, Purdue UniversityDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins UniversityWeldon School of Biomedical Engineering, Purdue UniversityAbstract Microneedles (MNs) have emerged as a promising technology for minimally invasive drug delivery, offering significant advantages in the treatment of ocular diseases. These miniaturized needles enable precise, localized drug delivery directly into specific tissues of the eye, such as the cornea, sclera, vitreous, or retina, while minimizing pain and discomfort. MNs can be fabricated from various biocompatible materials, including metals, silicon, and biodegradable polymers, making them highly adaptable to various clinical applications. Recent advancements in MN design include the integration of 3D printing technologies to create highly customized geometries for improved drug delivery precision, the use of smart materials that enable stimuli-responsive and sustained drug release, and the development of hybrid microneedles combining different polymers to enhance both mechanical strength and controlled drug release. These innovations have established MNs as a superior alternative to traditional methods like eye drops or intravitreal injections, which often face issues of limited bioavailability and patient compliance. This review summarizes the current state of research on MN-based ocular drug delivery, focusing on material developments, fabrication methods, drug release mechanisms, and implantation techniques. Future directions for MN technology in ophthalmology are also discussed, highlighting its potential to improve treatment outcomes for complex ocular diseases.https://doi.org/10.1038/s41427-025-00614-7 |
| spellingShingle | Junsang Lee Jinheon Jeong Van Phuc Nguyen Seokkyoon Hong Yannis M. Paulus Chi Hwan Lee Microneedles for controlled and sustained intraocular drug delivery NPG Asia Materials |
| title | Microneedles for controlled and sustained intraocular drug delivery |
| title_full | Microneedles for controlled and sustained intraocular drug delivery |
| title_fullStr | Microneedles for controlled and sustained intraocular drug delivery |
| title_full_unstemmed | Microneedles for controlled and sustained intraocular drug delivery |
| title_short | Microneedles for controlled and sustained intraocular drug delivery |
| title_sort | microneedles for controlled and sustained intraocular drug delivery |
| url | https://doi.org/10.1038/s41427-025-00614-7 |
| work_keys_str_mv | AT junsanglee microneedlesforcontrolledandsustainedintraoculardrugdelivery AT jinheonjeong microneedlesforcontrolledandsustainedintraoculardrugdelivery AT vanphucnguyen microneedlesforcontrolledandsustainedintraoculardrugdelivery AT seokkyoonhong microneedlesforcontrolledandsustainedintraoculardrugdelivery AT yannismpaulus microneedlesforcontrolledandsustainedintraoculardrugdelivery AT chihwanlee microneedlesforcontrolledandsustainedintraoculardrugdelivery |